EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The key role of matrix stiffness in colorectal cancer immunotherapy: mechanisms and therapeutic strategies

Engeng Chen, Zhiru Zeng, Wei Zhou

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2024-11 · 1879 (6) · 189198

DOI: 10.1016/j.bbcan.2024.189198 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2024-11. Verfasst von Engeng Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal Surgery, Sir Run Run Shaw Hospital of Zhejiang University, Hangzhou 310016, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Extracellular Matrix, Tumor Microenvironment, Immunotherapy. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 158 Literaturangaben. Gefördert von: Medical Science and Technology Project of Zhejiang Province, Natural Science Foundation of Zhejiang Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Increased matrix stiffness within the colorectal cancer (CRC) tumor microenvironment (TME) has emerged as a pivotal determinant of immunotherapy outcomes. This review discusses the role of aberrant extracellular matrix (ECM) deposition and cross-linking in augmenting matrix stiffness, a phenomenon that not only scaffolds the tumor architecture but also contributes to tumorigenicity and immunologic evasion. Herein, we critically appraise the influence of matrix stiffness on the immunotherapeutic landscape of CRC, focusing on its capacity to impede therapeutic efficacy by modulating immune cell infiltration, activation, and functional performance. The review explores the molecular dynamics whereby matrix stiffness prompts tumor evolution, highlighting the integral role of integrin signaling, cancer-associated fibroblasts (CAFs), and the process of epithelial-mesenchymal transition (EMT). We bring to the fore the paradoxical impact of an indurated ECM on immune effector cells, chiefly T cells and macrophages, which are indispensable for immune surveillance and the execution of immunotherapeutic strategies, yet are markedly restrained by a fibrotic matrix. Furthermore, we examine how matrix stiffness modulates immune checkpoint molecule expression, thereby exacerbating the immunosuppressive milieu within the TME and attenuating immunotherapeutic potency. Emergent therapeutic regimens targeting matrix stiffness-including matrix modulators, inhibitors of mechanotransduction signaling pathways, and advanced biomaterials that mimic the ECM-proffer novel modalities to potentiate immunotherapy responsiveness. By refining the ECM's biomechanical attributes, the mechanical barriers posed by the tumor stroma can be improved, facilitating robust immune cell penetration and activity, and thereby bolstering the tumor's susceptibility to immunotherapy. Ongoing clinical trials are evaluating these innovative treatments, particularly in combination with immunotherapies, with the aim of enhancing clinical outcomes for CRC patients afflicted by pronounced matrix stiffness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsExtracellular MatrixTumor MicroenvironmentImmunotherapyHumansEpithelial-Mesenchymal TransitionCancer-Associated FibroblastsAnimals

Stichwörter der Autor:innen

Colorectal cancer immunotherapyMatrix stiffnessTherapeutic strategies

Autor:innen und Institutionen

  • Department of Colorectal Surgery, Sir Run Run Shaw Hospital of Zhejiang University, Hangzhou 310016, China.
  • Department of Rheumatology and Immunology, the Second Affiliated Hospital of Zhejiang University, Hangzhou 310009, China.
  • Department of Colorectal Surgery, Sir Run Run Shaw Hospital of Zhejiang University, Hangzhou 310016, China. Electronic address: weizhou_srrsh@zju.edu.cn.

Förderung

  • Medical Science and Technology Project of Zhejiang Province
  • Natural Science Foundation of Zhejiang Province
  • National Natural Science Foundation of China

Zitieren

APA

Chen, E., Zeng, Z., & Zhou, W. (2024). The key role of matrix stiffness in colorectal cancer immunotherapy: mechanisms and therapeutic strategies. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1879(6), 189198. https://doi.org/10.1016/j.bbcan.2024.189198

Vancouver

Chen E, Zeng Z, Zhou W. The key role of matrix stiffness in colorectal cancer immunotherapy: mechanisms and therapeutic strategies. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2024;1879(6):189198. doi:10.1016/j.bbcan.2024.189198

BibTeX
@article{Chen2024,
  author = {Chen, Engeng and Zeng, Zhiru and Zhou, Wei},
  title = {The key role of matrix stiffness in colorectal cancer immunotherapy: mechanisms and therapeutic strategies},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2024},
  volume = {1879},
  number = {6},
  pages = {189198},
  doi = {10.1016/j.bbcan.2024.189198}
}
Kostenlos starten →